Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

140.50 +3.51 (+2.56%)
Streaming Delayed Price Updated: 1:26 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina Inc

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Next-Generation Sequencing: Helping to Better Understand the Impact of Climate Change in Our Future
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change
Exposures Climate
Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Emerging Trends, Top Growing Segments and Future Indusrtry Developments
Northbrook, IL -- (SBWIRE) -- 10/26/2021 -- Single-cell Analysis Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business... 
Via SBWire
'Halftime Report' Final Trades From Oct. 25: Illumina, JPMorgan, And More
On CNBC’s "Halftime Report" f... 
Via Benzinga
Companion Diagnostics Market : Industry-Specific Challenges, Opportunities and Trends Affecting the Growth
Northbrook, IL -- (SBWIRE) -- 10/21/2021 -- Companion Diagnostics Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business... 
Via SBWire
Illumina to Host Inaugural ESG Investor Event on Tuesday, November 16, 2021
SOURCE: Illumina 
Via 3BL Media
Illumina Named to Forbes World's Best Employer List
SOURCE: Illumina 
Via 3BL Media
Illumina Recognized As #20 on Fortune's Change the World List
SOURCE: Illumina 
Via 3BL Media
"Pharmacogenomics Saved My Life"
SOURCE: Illumina 
Via 3BL Media
Topics Product Recall
Exposures Legal Product Safety
Illumina Commits to 100 Percent Clean, Renewable Energy from San Diego Community Power
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Economy Emissions
Exposures Climate Economy
Bet On Biopharma: Data, Digitization, Discovery
The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the... 
Via Talk Markets
Illumina Insider Sold $1.2M In Company Stock
Alexander Aravanis, SVP And Chief Technology Officer at Illumina (NASDAQ:ILMN), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Illumina Launches New Employee Resource Group iLatinx During Hispanic Heritage Month
SOURCE: Illumina 
Via 3BL Media
Cancer Profiling Market Worth $13.9 Billion by 2025 – Key Players are Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US)
Via AB Newswire
Illumina Celebrates International Equal Pay Day
SOURCE: Illumina 
Via 3BL Media
Global Nuclease Market: What Are the Key Trends in Market? with Top Companies Like: MercK, Illumina, Thermo Fisher Scientific
The global Nuclease market is extensively evaluated by seasoned research analysts to help readers to expand their market knowledge and become aware of future market changes ahead of time. 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
Why Shares of Ilumina Slumped 11.3% in September
The company's merger with GRAIL concerned investors. 
Via The Motley Fool
SBTi Validates and Approves Illumina's Climate Action Targets
SOURCE: Illumina 
Via 3BL Media
Topics Emissions
San Diego Squared Announces 2021 STEM Educators Awards Recipients
SOURCE: Illumina 
Via 3BL Media
Illumina's Sustainability Efforts Rewarded With Gold Rating From EcoVadis
SOURCE: Illumina 
Via 3BL Media
Microfluidics Market Worth $58.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
Microfluidics Market categorizes the global market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics),... 
Via SBWire
Exposures COVID-19
Bioinformatics Market Worth $21.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global bioinformatics market is projected to reach $21.8 billion by 2026. Bioinformatics platforms market report provides crucial industry insights that will help your business grow. 
Via SBWire
Exposures COVID-19
Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation
SOURCE: Illumina 
Via 3BL Media
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Some trends will persist for decades. 
Via The Motley Fool
Illumina's Spotlight on Ovarian Cancer: Understanding Tumors Through Comprehensive Genomic Profiling
SOURCE: Illumina 
Via 3BL Media
On World Cancer Research Day, Illumina Highlights the Transformative Power of Genomics
SOURCE: Illumina 
Via 3BL Media
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death
Cancer Diagnostics Market Worth $26.6 Billion by 2026 – Growing Focus on Personalized Medicine and Leading Key Players
The global cancer diagnostics market size is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR of 11.5% during the forecast period 
Via SBWire
For the Fourth Consecutive Year, Illumina Was Recognized As a Platinum Tier SANDAG iCommute Diamond Award Winner
SOURCE: Illumina 
Via 3BL Media
Topics Emissions
Illumina Begins Climate Week by Highlighting How Sequencing Supports Resilient Responses to Climate Change
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Death
Exposures Climate Death
Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
SOURCE: Illumina 
Via 3BL Media
Next-generation Sequencing (NGS) Market worth $24.2 billion by 2026 | Key Players are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US)
Via AB Newswire
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.